Cardio-kidney-metabolic protective effects of semaglutide across the spectrum of chronic kidney disease

doi:10.5527/wjn.v14.i4.109457

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

(48)

(110)

(0)

(9)

(3630)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Nephrology

ISSN

2220-6124

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Nephrol. Dec 25, 2025; 14(4): 109457
Published online Dec 25, 2025. doi: 10.5527/wjn.v14.i4.109457

Full Size Figure Download Figure

Figure 4 The theoretical benefits of delaying onset of kidney failure, in terms of years gained, for patients in Evaluate Renal Function with Semaglutide Once Weekly treated with semaglutide vs placebo, if the amelioration of estimated glomerular filtration rate decline occurs a constant rate with semaglutide. eGFR: Estimated glomerular filtration rate; CKD: Chronic kidney disease; FLOW: Evaluate Renal Function with Semaglutide Once Weekly.

Citation: Economos H, MacIsaac RJ. Cardio-kidney-metabolic protective effects of semaglutide across the spectrum of chronic kidney disease. World J Nephrol 2025; 14(4): 109457
URL: https://www.wjgnet.com/2220-6124/full/v14/i4/109457.htm
DOI: https://dx.doi.org/10.5527/wjn.v14.i4.109457

Economos H, MacIsaac RJ. Cardio-kidney-metabolic protective effects of semaglutide across the spectrum of chronic kidney disease. World J Nephrol 2025; 14(4): 109457 [PMID: 41479840 DOI: 10.5527/wjn.v14.i4.109457]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.